What is associated with Atarax (hydroxyzine) overdose?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: June 20, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the FDA Drug Label

The most common manifestation of hydroxyzine overdosage is hypersedation. Other reported signs and symptoms were convulsions, stupor, nausea and vomiting. ... Hydroxyzine overdose may cause QT prolongation and Torsade de Pointes The following are associated with Atarax (hydroxyzine) overdose:

  • Hypersedation
  • Convulsions
  • Stupor
  • Nausea and vomiting
  • QT prolongation
  • Torsade de Pointes 1

From the Research

Hydroxyzine (Atarax) overdose is associated with sedation, confusion, hallucinations, and in severe cases, seizures or respiratory depression, with a lower likelihood of antimuscarinic findings compared to diphenhydramine poisoning, as shown in a recent cohort analysis 2.

Key Associations

  • Sedation
  • Confusion
  • Hallucinations
  • Blurred vision
  • Dry mouth
  • Urinary retention
  • Tachycardia
  • Hyperthermia
  • Seizures or respiratory depression in severe cases
  • QT interval prolongation, potentially leading to cardiac arrhythmias, as highlighted in a study on the risk of QT prolongation and torsade de pointes associated with hydroxyzine use 3

Important Considerations

  • Children are particularly susceptible to CNS effects and may experience paradoxical excitation
  • Treatment is primarily supportive, focusing on maintaining airway, breathing, and circulation
  • Activated charcoal may be administered if the ingestion was recent
  • Benzodiazepines can help manage seizures, while physostigmine might be considered for severe anticholinergic symptoms under careful medical supervision
  • Cardiac monitoring is important due to potential QT prolongation, as emphasized in a study on the cardiac safety profile of hydroxyzine 3
  • Most patients recover fully with appropriate supportive care, though severe overdoses can be life-threatening, particularly in patients with pre-existing cardiac conditions or when hydroxyzine is combined with other CNS depressants

Recent Findings

  • A cohort analysis of antimuscarinic effects in hydroxyzine and diphenhydramine-poisoned patients found that hydroxyzine-poisoned patients had lower rates and relative risk of developing antimuscarinic findings or receiving physostigmine 2
  • The clinical manifestations of hydroxyzine exposures are consistent with the pharmacology of hydroxazine, and clinicians should not generalize the illness script of diphenhydramine exposures to hydroxyzine exposures 2

Related Questions

What is the management for a 19-year-old male who took an unknown amount of diazepam (alprazolam) and doxycycline (antibiotic) 4 hours ago in a suicide attempt with a Glasgow Coma Scale (GCS) of 15?
Does a 28-year-old patient with anxiety, a body mass index (BMI) of 18, recent cessation of marijuana and vaping, and possible left heart enlargement on electrocardiogram (EKG) with sinus rhythm require referral and should Adderall (amphetamine and dextroamphetamine) be continued?
What are the next steps for a 36-year-old patient with Attention Deficit Hyperactivity Disorder (ADHD) experiencing jitteriness and increased talkativeness while taking Adderall (amphetamine and dextroamphetamine) 20mg?
What is the recommended management for a 42-year-old female with a history of Attention Deficit Hyperactivity Disorder (ADHD) and depression, currently taking Adderall (amphetamine and dextroamphetamine) 15mg twice a day?
What is the recommended treatment for a 16-year-old with Attention Deficit Hyperactivity Disorder (ADHD)?
What causes flushed skin?
What is the normal range of alpha-fetoprotein (AFP) according to age and gender?
What is the management approach for an infant with medullary nephrocalcinosis, significant weight loss (600 grams), and vomiting postnatally?
What are the differential diagnoses and initial workup for an infant presenting with medullary nephrocalcinosis, significant weight loss, and vomiting?
What are the diagnostic criteria and treatment options for Bartter syndrome?
Can diabetes cause interstitial nephritis?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.